DG

Dnyaneshwar Ganpat Kumbhar

Active Director Designated Partner DIN 10471855
DIN 10471855 First appointment Jan 2024
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Dnyaneshwar Ganpat Kumbhar

Data last updated:

Dnyaneshwar Ganpat Kumbhar is a Designated Partner at Medsource Clinical Research Llp (since 2024).

DIN 10471855
Primary Designation Designated Partner
First Appointment 19 Jan 2024
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner19 Jan 20242024Active

Board colleagues of Dnyaneshwar Ganpat Kumbhar

NameDINCompanyDesignation
Anil Mhalappa Bhalerao10471854Medsource Clinical Research LlpDesignated Partner
Gaurav Suhas Patil09308820Medsource Clinical Research LlpDesignated Partner
Pravin Bhimrao Kamble10605430Medsource Clinical Research LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Medsource Clinical Research Llp
Premium access

Shareholding and investment profile for Dnyaneshwar Ganpat Kumbhar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Dnyaneshwar Ganpat Kumbhar

Dnyaneshwar Ganpat Kumbhar currently holds 1 directorship: Medsource Clinical Research Llp (Designated Partner, since 19 Jan 2024).

Dnyaneshwar Ganpat Kumbhar was first appointed on 19 Jan 2024 as Designated Partner at Medsource Clinical Research Llp.

The current boards of Dnyaneshwar Ganpat Kumbhar's companies include Anil Mhalappa Bhalerao (Medsource Clinical Research Llp), Gaurav Suhas Patil (Medsource Clinical Research Llp), Pravin Bhimrao Kamble (Medsource Clinical Research Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available